585 related articles for article (PubMed ID: 26806492)
1. New insights: A role for O-GlcNAcylation in diabetic complications.
Peterson SB; Hart GW
Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
[TBL] [Abstract][Full Text] [Related]
2. The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.
Semba RD; Huang H; Lutty GA; Van Eyk JE; Hart GW
Proteomics Clin Appl; 2014 Apr; 8(3-4):218-31. PubMed ID: 24550151
[TBL] [Abstract][Full Text] [Related]
3. Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications.
Qin CX; Sleaby R; Davidoff AJ; Bell JR; De Blasio MJ; Delbridge LM; Chatham JC; Ritchie RH
Pharmacol Res; 2017 Feb; 116():45-56. PubMed ID: 27988387
[TBL] [Abstract][Full Text] [Related]
4. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAc modification, insulin signaling and diabetic complications.
Issad T; Masson E; Pagesy P
Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
[TBL] [Abstract][Full Text] [Related]
6. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats.
Akimoto Y; Hart GW; Wells L; Vosseller K; Yamamoto K; Munetomo E; Ohara-Imaizumi M; Nishiwaki C; Nagamatsu S; Hirano H; Kawakami H
Glycobiology; 2007 Feb; 17(2):127-40. PubMed ID: 17095531
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAc modification of nucleocytoplasmic proteins and diabetes.
Akimoto Y; Hart GW; Hirano H; Kawakami H
Med Mol Morphol; 2005 Jun; 38(2):84-91. PubMed ID: 15944815
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein
Chen Y; Zhao X; Wu H
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1911-1924. PubMed ID: 31462094
[TBL] [Abstract][Full Text] [Related]
9. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
10. Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications.
Chatham JC; Young ME; Zhang J
Curr Opin Pharmacol; 2021 Apr; 57():1-12. PubMed ID: 32937226
[TBL] [Abstract][Full Text] [Related]
11. Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy.
Gurel Z; Sieg KM; Shallow KD; Sorenson CM; Sheibani N
Mol Vis; 2013; 19():1047-59. PubMed ID: 23734074
[TBL] [Abstract][Full Text] [Related]
12. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.
Chatham JC; Nöt LG; Fülöp N; Marchase RB
Shock; 2008 Apr; 29(4):431-40. PubMed ID: 17909453
[TBL] [Abstract][Full Text] [Related]
13. Protein O-GlcNAcylation in diabetes and diabetic complications.
Ma J; Hart GW
Expert Rev Proteomics; 2013 Aug; 10(4):365-80. PubMed ID: 23992419
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAcylation, a sweet link to the pathology of diseases.
Nie H; Yi W
J Zhejiang Univ Sci B; 2019 May; 20(5):437-448. PubMed ID: 31090269
[TBL] [Abstract][Full Text] [Related]
15. Roles of O-GlcNAc in chronic diseases of aging.
Banerjee PS; Lagerlöf O; Hart GW
Mol Aspects Med; 2016 Oct; 51():1-15. PubMed ID: 27259471
[TBL] [Abstract][Full Text] [Related]
16. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
[TBL] [Abstract][Full Text] [Related]
17. O-Linked β-
Gurel Z; Sheibani N
Clin Sci (Lond); 2018 Jan; 132(2):185-198. PubMed ID: 29352075
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAc signaling: a metabolic link between diabetes and cancer?
Slawson C; Copeland RJ; Hart GW
Trends Biochem Sci; 2010 Oct; 35(10):547-55. PubMed ID: 20466550
[TBL] [Abstract][Full Text] [Related]
19. The hexosamine signaling pathway: deciphering the "O-GlcNAc code".
Love DC; Hanover JA
Sci STKE; 2005 Nov; 2005(312):re13. PubMed ID: 16317114
[TBL] [Abstract][Full Text] [Related]
20. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
